BACKGROUND: Standard surgical procedures used for the treatment of @entity5845 constitute optional treatments for @entity6 ( @entity6 ). The aim of the present study was to evaluate the short- and mid-term effects of laparoscopic sleeve gastrectomy (SG) with ileal interposition (II) in @entity6 @entity1 (n = 30). METHODS: The variables investigated were the feasibility of the procedure, remission/alleviation of the disease, morbidity, mortality, and @entity353 . @entity1 were followed during a period of 6-18 months after surgery. RESULTS: The average time required for the surgical procedure was 181.47    53.23 min, and the mean duration of postoperative hospital stay was 3.17    0.79 days. There were no intraoperative complications, and none of the @entity1 required conversion to open surgery. Postoperatively, all @entity1 experienced a significant @entity353 : i.e., the mean body mass index (BMI) values prior to and following surgery were significantly different (P = 0.0001). Postoperative levels of glycosylated hemoglobin, fasting @entity413 , and @entity9208 were significantly reduced (P = 0.0001, 0.0001, and 0.0004, respectively) from those detected prior to surgery. Remission of @entity6 was observed in 80% of the @entity1 over the follow-up period, and these subjects no longer required treatment with hypoglycemic drugs or diet. The remaining 20% of @entity1 presented significant improvement in their condition but needed an oral hypoglycemic medication. CONCLUSIONS: Adequate glycemic control, adjustable @entity353 , and absence of @entity3147 were the main benefits offered by the surgical intervention. The results indicate that @entity44607 treatment could be a promising alternative for @entity1 with @entity6 .

Short-term and mid-term control of XXXX by laparoscopic sleeve gastrectomy with ileal interposition.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity353 :: ('MESH:D015431', 'Disease') :: ['weight loss'] @entity6 :: ('MESH:D003920', 'Disease') :: ['T2DM', 'type 2 diabetes mellitus'] @entity9208 :: ('MESH:D019270', 'Chemical') :: ['fructosamine'] @entity5845 :: ('MESH:D009767', 'Disease') :: ['morbid obesity'] @entity44607 :: ('6407', 'Gene') :: ['SG/II'] @entity3147 :: ('MESH:D044342', 'Disease') :: ['nutritional deficiencies'] @entity413 :: ('MESH:D005947', 'Chemical') :: ['glucose']
@entity6 :: (MESH:D003920,Disease) :: ['type 2 diabetes mellitus']
